Human T-lymphotropic virus 1

From WikiMD's WELLNESSPEDIA

HTLV-1 and HIV-1 EM 8241 lores

Human T-lymphotropic virus 1 (HTLV-1) is a retrovirus that infects T-lymphocytes, a type of white blood cell that plays a central role in the immune system. HTLV-1 is associated with several diseases, including adult T-cell leukemia/lymphoma (ATLL) and HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP).

Virology[edit]

HTLV-1 is a member of the Deltaretrovirus genus within the Retroviridae family. The virus has a single-stranded RNA genome that is reverse transcribed into DNA and integrated into the host cell's genome. The viral genome encodes several proteins, including gag, pol, and env, which are essential for viral replication and assembly.

Transmission[edit]

HTLV-1 is transmitted through several routes:

Epidemiology[edit]

HTLV-1 is endemic in certain regions, including Japan, the Caribbean, parts of Africa, and South America. The prevalence of HTLV-1 infection varies widely, with some areas having infection rates as high as 10%.

Clinical Manifestations[edit]

HTLV-1 infection can lead to several clinical conditions:

Diagnosis[edit]

Diagnosis of HTLV-1 infection is typically made through serological testing to detect antibodies against the virus. Polymerase chain reaction (PCR) can also be used to detect viral DNA in infected cells.

Treatment[edit]

There is currently no cure for HTLV-1 infection. Treatment focuses on managing symptoms and complications. Antiretroviral therapy has limited efficacy in HTLV-1 infection, and treatment for ATLL may include chemotherapy and antiviral drugs.

Prevention[edit]

Preventive measures include:

  • Screening of blood products for HTLV-1
  • Encouraging safe sex practices
  • Avoiding breastfeeding by HTLV-1 infected mothers

See Also[edit]

References[edit]


External Links[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.